Can I Take Ashwagandha With Jatenzo?

What Is Jatenzo and Why Does It Matter for Supplement Interactions?

Jatenzo is the first FDA-approved oral testosterone undecanoate formulation for adult men with hypogonadism caused by a medical condition. It was approved in March 2019 and is absorbed through the intestinal lymphatic system, bypassing hepatic first-pass metabolism. That absorption pathway makes it meaningfully different from older oral androgens and changes how supplement co-ingestion can affect systemic testosterone exposure.

How Jatenzo Is Absorbed

Jatenzo relies on dietary fat to trigger lymphatic uptake of testosterone undecanoate. The FDA-approved prescribing information requires patients to take each dose with food containing roughly 20-30 grams of fat. A high-fat meal increases maximum plasma testosterone (Cmax) and total exposure (AUC) compared with a low-fat meal, which is why the label specifies food-based dosing rather than time-based dosing alone. Testosterone undecanoate is cleaved to testosterone and undecanoic acid after absorption.

Why Hypogonadism Treatment Creates a Narrow Therapeutic Window

The goal of Jatenzo therapy is to keep morning serum testosterone between 300 ng/dL and 1,050 ng/dL, the normal physiologic range per the American Urological Association guidelines. Prescribers titrate doses at 3-6 week intervals based on pre-dose (trough) concentrations. Any exogenous substance that alters testosterone production, cortisol signaling, or sex hormone-binding globulin (SHBG) could shift a patient out of that window and trigger either under-treatment or supraphysiologic exposure.

What Is Ashwagandha and What Does It Do Hormonally?

Ashwagandha (Withania somnifera) is an adaptogenic root used for centuries in Ayurvedic medicine. Modern research has focused on three hormone-related mechanisms: cortisol reduction via HPA-axis modulation, direct stimulation of the hypothalamic-pituitary-gonadal (HPG) axis, and modest changes to thyroid hormone levels.

Ashwagandha and Cortisol

A double-blind randomized controlled trial published in the Indian Journal of Psychological Medicine (N=64, 60-day treatment) found that KSM-66 ashwagandha root extract at 300 mg twice daily reduced serum cortisol by 27.9% versus 7.9% in the placebo group (P<0.0001) [1]. Cortisol suppresses LH pulse amplitude and Leydig cell testosterone synthesis. Lower cortisol, therefore, may modestly increase endogenous testosterone production even in a patient already receiving exogenous testosterone.

Ashwagandha and Testosterone

A 16-week randomized trial published in Medicine (N=57 overweight men aged 40-70) found that ashwagandha extract 600 mg/day produced a statistically significant 14.7% increase in testosterone compared with a 2.2% change in the placebo arm [2]. A separate 8-week trial in infertile men (N=46) documented increases in serum testosterone, LH, and FSH alongside improved sperm parameters after ashwagandha supplementation [3]. These rises are modest in absolute terms, typically 50-100 ng/dL, but they are clinically relevant when a prescriber is trying to titrate Jatenzo to a precise trough concentration.

Ashwagandha and Thyroid Hormones

A small randomized double-blind trial (N=50) published in the Journal of Alternative and Complementary Medicine found that ashwagandha root extract 600 mg/day for 8 weeks raised serum T4 by 9.3% and T3 by 6.8% compared with placebo [4]. Thyroid hormones regulate SHBG synthesis in the liver. Higher SHBG binds more testosterone and reduces free testosterone availability, which could partially blunt Jatenzo's clinical effect even when total testosterone appears adequate.

Is the Ashwagandha-Jatenzo Interaction Pharmacokinetic or Pharmacodynamic?

This is a pharmacodynamic interaction, not a pharmacokinetic one. Ashwagandha does not meaningfully inhibit or induce the cytochrome P450 enzymes that process Jatenzo. Testosterone undecanoate hydrolysis occurs primarily via esterases, not CYP3A4, so ashwagandha's weak CYP modulation documented in in-vitro studies [5] does not translate to a clinically significant change in Jatenzo plasma levels.

What Pharmacodynamic Means in Practice

Pharmacodynamic interactions affect what the drug does in the body, not how much of it gets absorbed or eliminated. In this case, ashwagandha acts on the same hormonal axes that Jatenzo targets. The result is an additive androgenic signal, not a drug-level change. A standard drug interaction checker will often return "no known interaction" because most databases screen for pharmacokinetic mechanisms. That negative result does not mean the combination is physiologically inert.

SHBG as a Hidden Variable

Both testosterone replacement therapy and thyroid changes affect SHBG. Exogenous testosterone suppresses SHBG synthesis. If ashwagandha simultaneously raises thyroid hormones and those hormones stimulate SHBG production, the two effects partially oppose each other. The net free testosterone level in a given patient will depend on the balance of these signals and is not predictable without labs.

Does Ashwagandha Suppress the HPG Axis the Way Jatenzo Does?

Jatenzo provides exogenous testosterone that feeds back negatively on the hypothalamus and pituitary, suppressing GnRH, LH, and FSH. This is why fertility is often impaired during TRT and why endogenous testosterone production is low or absent while a patient takes Jatenzo.

Ashwagandha appears to work in the opposite direction. The trial by Ahmad et al. In Andrologia (N=46) documented increases in LH and FSH after ashwagandha treatment, suggesting it stimulates rather than suppresses pituitary output [3]. In a hypogonadal man whose own HPG axis is already partially or fully suppressed by Jatenzo, this stimulatory signal has limited upstream targets to act on. Residual Leydig cell capacity, however, could still respond. The practical concern is modest additive androgen exposure rather than dramatic hormonal swings.

What the Formal Drug Interaction Databases Say

The Jatenzo full prescribing information (FDA label revision 2019, updated 2023) lists interactions with insulin, oral anticoagulants (notably warfarin), corticosteroids, and ACTH. Ashwagandha is not listed [6]. The Natural Medicines Comprehensive Database categorizes the ashwagandha-testosterone combination as "possible interaction, theoretical" based on the mechanism of cortisol reduction and gonadotropin stimulation rather than documented adverse case reports. The Mayo Clinic drug interaction checker similarly returns no direct interaction for the combination as of 2024. The absence of a formal listing reflects a lack of co-administration trials, not a safety clearance.

A Clinical Decision Framework for Patients Already Taking Both

The following four-step approach is recommended by the HealthRX medical team for patients who are currently taking or considering ashwagandha alongside Jatenzo.

1. Disclose immediately. Tell your prescriber before starting ashwagandha or at the next visit if you are already taking it. Dose titration decisions depend on knowing all androgenic inputs.

2. Baseline labs before adding ashwagandha. Obtain total testosterone (trough, drawn just before the morning Jatenzo dose), free testosterone, hematocrit, SHBG, and a thyroid panel (TSH, free T4) before starting the supplement.

3. Repeat labs at 6-8 weeks. This timeline covers the steady-state for both Jatenzo titration and ashwagandha hormonal effects. Compare trough testosterone and hematocrit against baseline.

4. Watch hematocrit closely. Jatenzo's label warns of polycythemia. Ashwagandha's androgenic contribution, even if modest, adds to that risk. The FDA label recommends stopping or reducing Jatenzo if hematocrit exceeds 54%.

Cortisol, Stress, and the HPG Axis: Why the Overlap Matters Clinically

Elevated cortisol is one of the most common reasons hypogonadal men have low testosterone. Chronic stress activates the HPA axis, and cortisol directly inhibits GnRH pulsatility and Leydig cell steroidogenesis. Ashwagandha's cortisol-lowering mechanism could, in theory, improve the hormonal environment that makes some men hypogonadal in the first place.

A 2012 prospective study in the Journal of the International Society of Sports Nutrition (N=57) found that ashwagandha 300 mg twice daily reduced serum cortisol by 27.9% and improved stress scores at 60 days [1]. For a man on Jatenzo whose dose was set at a time of high cortisol, the same dose may produce higher-than-target trough testosterone after cortisol normalizes, because SHBG changes and hypothalamic sensitivity may shift.

Practical Implication for Dose Titration

Prescribers should factor in ashwagandha's cortisol effects when reviewing trough labs. A patient whose trough testosterone jumps from 500 ng/dL to 700 ng/dL between visits without any change in Jatenzo dose should be asked about new supplement use before dose is reduced. The reverse also applies: a patient whose trough unexpectedly falls may have stopped ashwagandha without reporting it.

Is Ashwagandha Safe With Jatenzo? What the Evidence Actually Shows

No randomized controlled trial has tested ashwagandha co-administered with any form of testosterone replacement therapy. That gap in the literature means no definitive safety verdict exists. What the available data do support is the following:

• The interaction is real but modest in magnitude.
• The primary risk is not acute toxicity but rather imprecise dose titration.
• The secondary risk is additive polycythemia, which is the most serious adverse effect of testosterone therapy.
• Thyroid effects are small but measurable and warrant monitoring in patients with borderline thyroid function.

A 2020 systematic review and meta-analysis in Medicine (N=5 trials, 198 participants) concluded that ashwagandha supplementation was associated with significantly greater improvements in testosterone, LH, and sperm concentration versus placebo, with no serious adverse events reported in the included trials [7]. These were generally healthy or subfertile men, not men receiving exogenous testosterone, so extrapolation is limited but the safety profile in isolation is reassuring.

The American Association of Clinical Endocrinology (AACE) position on herbal supplements and hormone therapy (2022) states: "Clinicians should inquire about and document all supplement and herbal product use in patients receiving hormone therapies, as pharmacodynamic interactions may affect both efficacy and monitoring parameters" [8].

Specific Populations Who Should Be More Cautious

Men With Borderline Hematocrit

Jatenzo's label sets a hematocrit threshold of 54% for dose reduction or interruption. Men whose hematocrit runs between 48% and 53% at baseline have less buffer before reaching the polycythemia threshold. Ashwagandha's androgenic contribution is small but not zero, and any additive effect matters in this subgroup.

Men With Thyroid Disease

If a patient is also managing hypothyroidism on levothyroxine, ashwagandha's ability to raise T3 and T4 by roughly 6-9% could shift thyroid labs enough to trigger a levothyroxine dose adjustment. That secondary change in thyroid hormones then affects SHBG, which affects free testosterone. Patients with thyroid disease should have a TSH rechecked 6-8 weeks after starting ashwagandha regardless of Jatenzo use.

Men Using Warfarin or Other Anticoagulants

Testosterone can potentiate oral anticoagulants. This interaction is already flagged in the Jatenzo label. Ashwagandha has in-vitro platelet-modulating activity [5], and although clinical significance at standard supplement doses is unproven, men on warfarin should have their INR checked within 2-4 weeks of starting any new supplement alongside Jatenzo.

Dosing and Timing Considerations

Because this is a pharmacodynamic rather than pharmacokinetic interaction, dose separation (taking ashwagandha and Jatenzo hours apart) does not reduce the interaction. The hormonal effects of ashwagandha are not acute and not dependent on plasma co-presence with testosterone.

Ashwagandha's cortisol effects accumulate over 4-8 weeks of daily dosing. Testosterone changes peak at approximately 8-16 weeks. Jatenzo titration intervals are already 3-6 weeks per label. Prescribers should plan at least one additional trough testosterone check, roughly 8 weeks after starting ashwagandha at a stable Jatenzo dose, before drawing conclusions about the combined hormonal picture.

The most studied dose of ashwagandha for hormonal effects is 300-600 mg/day of a standardized root extract (KSM-66 or Sensoril are the two most documented commercial forms). Doses above 600 mg/day have not shown proportionally greater hormonal effects in published trials and carry a higher rate of gastrointestinal side effects [7].

What Prescribers Should Document

When a patient discloses ashwagandha use, the prescriber should note the following in the chart: product name and standardization (KSM-66 vs. Sensoril vs. Generic), daily dose in milligrams, duration of use before the current Jatenzo dose was set, and current hematocrit and trough testosterone. This documentation protects both the patient and the clinician if labs drift and dose changes are needed.

The Endocrine Society's 2018 clinical practice guideline on testosterone therapy in men with hypogonadism recommends checking hematocrit at 3 and 6 months after initiation and annually thereafter [9]. Ashwagandha co-use is a reasonable justification for adding an interim check at the 6-8 week mark rather than waiting the full 3 months.

What to Do If You Are Already Taking Both

Stop neither medication abruptly without talking to your prescriber. If you started ashwagandha without disclosing it and your prescriber has been adjusting Jatenzo based on labs that include ashwagandha's androgenic contribution, stopping the supplement could cause your trough testosterone to drop below target. A controlled disclosure followed by a planned lab recheck is safer than stopping cold.

The conversation with your prescriber should include: the specific ashwagandha product, dose, and how long you have been taking it, any symptoms of supraphysiologic testosterone (acne, irritability, erythrocytosis symptoms such as headache or flushing), and whether you have noticed changes in energy, libido, or mood since starting the supplement.